JP Morgan Chase’s Sotera Health SHC Stock Holding History

JP Morgan Chase’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,400	Closed	-$23.4K	–	7695
2024 Q3	$23.4K	Buy	+1,400	New	+$20.5K	﹤0.01%	6201

Other funds holding SHC

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

DCP

Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

JP Morgan Chase's SHC Position: Q2 2026 in Review

JP Morgan Chase increased its Sotera Health (SHC) stake by 129% in Q2 2026, buying an estimated $5.76M and bringing the position to 648,606 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2676.

JP Morgan Chase first reported a position in SHC in Q4 2020 and has held it in 23 quarters since. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

JP Morgan Chase held 648,606 shares of Sotera Health worth $11.6M as of Q2 2026.
JP Morgan Chase bought 365,643 Sotera Health shares in Q2 2026, an estimated $5.76M.
Sotera Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2676 holding.
JP Morgan Chase first reported a position in Sotera Health in Q4 2020 and has held it in 23 quarters since.
320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.